310 N. STATE STREET SUITE 208
LAKE OSWEGO OR 97034
855 855 4253
CEO/President:
Mark J. Ahn Ph.D.
Industry,Sector, Index:
SIC: 2834, Medical - Biomedical
Description:
Galena Biopharma, Inc. is a biopharmaceutical company that develops innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care. Galena Biopharma, Inc., formally known as RXi Pharmaceuticals Corporation, is based in Portland, Oregon.
Share Information
Market Value, $K:
207,670
Shares Outstanding, K:
83,070
% Held by Insiders:
5.80%
% Institutional Shareholders:
10.74%
Last Quarter Sales, $M:
N/C
Last Quarter Net Income, $M:
-9.29
Last Quarter EPS:
-0.11
P/E Ratio:
0.00
Annual EPS, $:
-0.20
Most Recent Earnings, $:
Annual Dividend Rate, $:
0
Most Recent Dividend:
Annual Dividend Yield, %:
0%
Most Recent Split:
Fundamental information provided by Zacks Investment Research, Inc.
Zacks does not represent, warrant,
or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever
to any party on account of any incompleteness of, inaccuracies in or untimeliness of the Zacks content provided
hereunder, or for any delay in reporting such data. Zacks expressly disclaims all warranties of fitness of the
Zacks content or computations and analyses thereof for a particular purpose or use.
